{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:00:38Z","timestamp":1769691638720,"version":"3.49.0"},"reference-count":12,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":4749,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Law. Med. Ethics"],"published-print":{"date-parts":[[2008]]},"abstract":"<jats:p>Screening for prostate cancer with the prostate-specific antigen (PSA) blood test is controversial, as evidence to date has not demonstrated such screening does more good than harm. While the potential benefit of PSA screening on reducing prostate cancer mortality has not been documented in randomized trials, many risks of PSA screening have been well documented. These risks include a substantially higher risk of a prostate cancer diagnosis over a screenee\u2019s lifetime, false-positive and false-negative test results, possible complications from biopsies done in response to suspicious test results, and substantial risks of side effects from subsequent prostate cancer treatments. Nevertheless, PSA screening is widespread in the United States, and many physicians in a national survey reported supporting routine PSA screening as well as getting PSA tests themselves, despite the lack of evidence.<\/jats:p>","DOI":"10.1111\/j.1748-720x.2008.00283.x","type":"journal-article","created":{"date-parts":[[2008,6,2]],"date-time":"2008-06-02T18:11:11Z","timestamp":1212430271000},"page":"396-402","source":"Crossref","is-referenced-by-count":28,"title":["Reactions of Potential Jurors to a Hypothetical Malpractice Suit Alleging Failure to Perform a Prostate-Specific Antigen Test"],"prefix":"10.1017","volume":"36","author":[{"given":"Michael J.","family":"Barry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela H.","family":"Wescott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen J.","family":"Reifler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchaio","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin W.","family":"Moulton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2021,1,1]]},"reference":[{"key":"S1073110500011244_bib5","unstructured":"5. The American Cancer Society, \u201cAmerican Cancer Society Guidelines for the Early Detection of Cancer,\u201d available at <http:\/\/www.cancer.org> (last visited March 3, 2008)."},{"key":"S1073110500011244_bib2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.11.1414"},{"key":"S1073110500011244_bib6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2007.07.030"},{"key":"S1073110500011244_bib11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.1.71"},{"key":"S1073110500011244_bib1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004720.pub2"},{"key":"S1073110500011244_bib4","first-page":"1871","article-title":"\u201cThe Liability of Giving Patients a Choice: Shared Decision Making and Prostate Cancer (Editorial),\u201d","volume":"71","author":"Woolf","year":"2005","journal-title":"American Family Physician"},{"key":"S1073110500011244_bib9","unstructured":"9. See Woolf, and Krist, , supra note 4."},{"key":"S1073110500011244_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0002-9343(02)01235-4","article-title":"\u201cWhy Is Prostate Cancer Screening So Common When the Evidence Is So Uncertain? A System without Negative Feedback,\u201d","volume":"113","author":"Woolf","year":"2002","journal-title":"American Journal of Medicine"},{"key":"S1073110500011244_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1525-1497.2003.20626.x","article-title":"\u201cPhysician Perspectives on the Importance of Facts Men Ought to Know about Prostate-Specific Antigen Testing,\u201d","volume":"18","author":"Chan","year":"2003","journal-title":"Journal of General Internal Medicine"},{"key":"S1073110500011244_bib12","unstructured":"12. See supra note 7."},{"key":"S1073110500011244_bib10","unstructured":"10. See Volk, et al., supra note 6."},{"key":"S1073110500011244_bib8","first-page":"15","article-title":"\u201cWinners and Losers,\u201d","author":"Merenstein","year":"2004","journal-title":"JAMA"}],"container-title":["Journal of Law, Medicine &amp; Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1748-720X.2008.00283.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1111\/j.1748-720X.2008.00283.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1073110500011244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T20:51:51Z","timestamp":1610657511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1073110500011244\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"alternative-id":["S1073110500011244"],"URL":"https:\/\/doi.org\/10.1111\/j.1748-720x.2008.00283.x","relation":{},"ISSN":["1073-1105","1748-720X"],"issn-type":[{"value":"1073-1105","type":"print"},{"value":"1748-720X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}